Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	-0.80	542.60	547.00
Graham Fair Price	42.33	18.05	12.68
PEG	-64.23	-0.53	1.48
Price/Book	-15.31	3.10	3.66
Price/Cash Flow	8.78	-168.90	155.28
Prices/Earnings	57.37	-52.96	-124.22
Price/Sales	-14.37	16.16	18.87
Price/FCF	8.78	-168.90	155.28
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-2.60	0.45	0.46
Operating Margin	1.80	-0.07	-0.08
ROA	-103.77	< 0.005	< 0.005
ROE	< 0.005	-0.01	-98.65
ROIC	< 0.005	< 0.005	-106.01
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	< 0.005	< 0.005	33.22
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.49	0.02	-96.59
EPS QOQ	0.84	-1.00	19.17
FCF QOQ	1.32	-1.79	35.94
Revenue QOQ	< 0.005	< 0.005	-57.02
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	87.96	78.39	-10.88
Days Sales Outstanding (DSO)	48.08	55.34	15.10
Inventory Turnover	1.02	1.15	12.21
Debt/Capitalization	0.46	0.44	-2.86
Quick Ratio	3.85	4.62	20.01
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	31.13	31.44	0.98
Cash	21.65	21.08	-2.62
Capex	-0.27	-0.23	13.68
Free Cash Flow	0.73	-0.58	-21.38
Revenue	6.05	6.04	-0.13
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	4.53	5.32	17.50
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	20.89	31.39	50.22
Naive Interpretation	Member

06 - Financial Health · Bad

Rating